AngioDynamics Inc.
December 09, 2024 - by Joey Ramson
$ANGO is making new 52 week highs and is leading the Prism MarketView MedDevices index. Before the open the company announced the FDA had granted clearance for its NanoKnife System in patients with immediate-risk prostate cancer.
